|1.||Crohn Disease (Crohn's Disease)
|1.||Cominelli, Fabio: 24 articles (04/2015 - 11/2002)|
|2.||Pizarro, Theresa T: 16 articles (04/2015 - 04/2003)|
|3.||Rivera-Nieves, Jesús: 13 articles (01/2013 - 11/2002)|
|4.||Bamias, Giorgos: 11 articles (01/2013 - 11/2002)|
|5.||Haller, Dirk: 10 articles (01/2014 - 05/2007)|
|6.||Rivera-Nieves, Jesus: 7 articles (11/2010 - 03/2005)|
|7.||Ley, Klaus: 6 articles (04/2015 - 08/2004)|
|8.||Heimesaat, Markus M: 6 articles (01/2014 - 01/2007)|
|9.||Bereswill, Stefan: 6 articles (01/2014 - 01/2007)|
|10.||Jedlicka, Paul: 6 articles (01/2013 - 05/2010)|
04/01/2015 - "Administration of R848 to adult SAMP mice increased migration of DC to the MLN and development of regulatory T cells there, and reduced the severity of ileitis. "
01/01/2012 - "The aim of this study was to determine the mechanism(s) of VSL#3-mediated protection on epithelial barrier function and to further investigate the "paradoxical" effects of TNF in preventing SAMP ileitis. "
01/01/2006 - "The aim of the present study was to develop a noninvasive imaging modality to detect and evaluate ileitis in SAMP1/YitFc (SAMP) mice. "
04/01/2015 - "Loss of CCL21 signaling and DC migration is required for development of ileitis in SAMP mice. "
04/01/2015 - "Young SAMP mice had reduced CCL21 expression and decreased DC migration before developing ileitis. "
|2.||infliximab (Remicade)FDA Link
04/01/2005 - "Among them, four had previously undergone intravenous infusion of infliximab with no significant response, nine had contraindications for intravenous infusion, and two had associated stenosing ileitis and severe coloproctitis. "
01/01/2008 - "The LIR!C-trial is a randomized multicenter trial that will provide evidence whether infliximab treatment or surgery is the best treatment for recurrent distal ileitis in Crohn's disease. "
05/01/2008 - "To determine the efficacy of infliximab in treatment of chronic refractory pouchitis complicated by ileitis, using a wireless capsule endoscopy. "
01/01/2008 - "Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial)."
05/01/2008 - "These preliminary results indicate that infliximab may be recommended for the treatment of chronic refractory pouchitis complicated by ileitis."
|3.||Interleukin-17 (Interleukin 27)IBA
07/01/2014 - "IL-17A was pathogenic, while IL-22 was protective against ileitis. "
06/01/2008 - "Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17."
10/01/2014 - "In contrast, ileal IL-23 expression, ER stress, lymph node IL-17A production, goblet cell loss, and ileitis development were microbiota-dependent. "
12/21/2009 - "Moreover, IL-23-dependent up-regulation of IL-22 was essential for the development of ileitis, whereas IL-17 was down-regulated and dispensable. "
|4.||Budesonide (Pulmicort)FDA LinkGeneric
04/01/2015 - "Budesonide is used as first-line treatment for a first episode of ileitis. "
10/01/1995 - "Effects of plain and controlled-ileal-release budesonide formulations in experimental ileitis."
05/23/1998 - "Controlled ileal release budesonide (9 mg daily) induces clinical remission in 60-70% of patients with Crohn's ileitis or right-sided colitis, and continued budesonide treatment has a finite effect on the duration of remission. "
11/01/2007 - "Localized eosinophilic ileitis with mastocytosis successfully treated with oral budesonide."
|5.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/08/2003 - "TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis."
09/01/2010 - "Feeding studies in tumor necrosis factor (TNF)Delta ARE/+ mice, a mouse model for experimental ileitis, revealed that neither VSL#3 nor L. "
11/01/2011 - "We studied the roles of RA in mice that overproduce tumor necrosis factor (TNF) and develop chronic ileitis (TNF_ARE mice). "
05/01/2011 - "By using a mouse model that develops Crohn's-like ileitis (tumor necrosis factor Δadenosine uracyl-rich element [TNFΔARE] mice) we examined the role of CCL25-CCR9 interactions for effector and Treg traffic using flow cytometry, quantitative reverse-transcription polymerase chain reaction, immunohistochemistry, immunoneutralization, and proliferation analyses. "
01/01/2006 - "MAdCAM-1-targeted MB (MB(M)) were tested for binding specificity on MAdCAM-1 protein and tumor necrosis factor (TNF)-stimulated SVEC4-10 endothelial cells using an in vitro flow chamber assay and for their ability to detect and quantify ileitis by intravital microscopy and transabdominal US. "
|6.||Mesalamine (Mesalazine)FDA LinkGeneric
06/01/2008 - "Rats were treated orally with BGMP and its efficacy compared with that of oral 5-aminosalicylic acid or vehicle, starting 2 days before ileitis induction. "
03/01/1999 - "Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial."
07/01/1992 - "Coated forms of mesalamine have a potential advantage in the treatment of Crohn's ileitis in that these forms do not require bacterial cleavage for activity. "
06/01/2000 - "The study was carried out in 19 patients submitted to radical surgery for Crohn's ileitis or ileocolitis, under oral prophylactic treatment with 5-ASA (Asacol). "
03/01/2010 - "These abnormal findings within the PPs were associated with minimal mucosal lesions but not with backwash ileitis; both electron microscopy and magnifying endoscopy confirmed that these lesions were reversible following remission with prednisolone-mesalazine therapy. "
08/15/2004 - "The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii."
06/01/1985 - "The omega-antigen was also present in the lesions of hamster proliferative ileitis."
06/01/1985 - "Demonstration of a new intracellular antigen in porcine intestinal adenomatosis and hamster proliferative ileitis."
01/01/2002 - "After etiotropic treatment, 2 patients continued to have the steady pain syndrome in the right iliac area, which is likely to be associated with periileitis and, 46 patients developed chronic Yersinia ileitis, as evidenced by their positive serological reactions to antigens and iliac morphological findings. "
02/01/1988 - "Fluorescent antibody to "omega" campylobacter antigen present in porcine intestinal adenomatosis and hamster proliferative ileitis was demonstrated at the site of bacterial colonization within hyperplastic epithelial cells of six colons from ferrets affected with proliferative colitis."
|8.||Ursodeoxycholic Acid (Urso)FDA LinkGeneric
10/01/2004 - "Ursodeoxycholic acid ameliorates experimental ileitis counteracting intestinal barrier dysfunction and oxidative stress."
05/01/1994 - "In basic experiment using dogs with or without experimentally induced ileitis by trinitrobenzene sulfonic acid, ursodeoxycholic acid (UDCA) solution of several concentrations was given into the duodenum (corresponding to oral test) or the terminal ileum. "
12/01/1997 - "The objective of this study was to determine whether urso- (UDC), cheno- (CDC), and taurochenodeoxycholic acid (TCDC) exert a pro- or antiinflammatory action in the acute and chronic phase of the indomethacin model of a long lasting ileitis in rats. "
04/01/1982 - "Patients with Crohn's ileitis tended to preserve normal fasting total bile acid pools by increased synthesis of primary bile acids and efficient absorption of deoxycholic acid and ursodeoxycholic acid by the normal colon. "
|9.||Beclomethasone (Beclometasone)FDA Link
06/01/2011 - "Beclomethasone dipropionate in Crohn's ileitis: a randomised, double-blind trial."
06/01/2011 - "To evaluate the efficacy and tolerability of beclomethasone dipropionate for maintaining remission induced by a short course of systemic steroids in patients with Crohn's ileitis with or without right colonic involvement. "
06/01/2011 - "These results demonstrate that beclomethasone dipropionate significantly reduces the relapse rate in post-active Crohn's ileitis patients compared with placebo after induction of remission with a short course of systemic steroids, and is well tolerated."
01/01/2003 - "These results indicate that the oral administration of IS-741 inhibits neutrophil infiltration into inflamed lesions, and is effective for attenuating rat TNBS ileitis. "
01/01/2003 - "In this study, we used rat trinitrobenzene sulfonic acid (TNBS) ileitis as a Crohn's disease model, and investigated the effects of oral IS-741 (which inhibits the expression of Mac-1, a cell adhesion molecule) on leukocyte-endothelial interactions. "
03/01/2008 - "Development of terminal ileitis after colectomy and IPAA can occur in children with UC. "
05/01/2004 - "The patient has done fairly well on routine medications, but this case represents ileitis developing post colectomy that did not exist previous to colectomy and raises the questions for the following presentations and discussions in this workshop symposium."
01/01/1991 - "As it prevents coloileal reflux, this assembly may prevent ileitis after right colectomy. "
01/01/1970 - "The natural history of post-colectomy ileitis."
11/01/2011 - "We evaluated terminal ileal sections from original colectomies of 2213 patients with either UC or idiopathic inflammatory bowel disease of indeterminate type, collected during a 21-year period, for extent and severity of chronic and active ileitis. "
05/01/2014 - "The tentative clinical diagnosis of Crohn's ileitis was supported at computed tomographic examination, at laparotomy and at inspection of the resected ileal segment. "
06/01/2003 - "The most frequent finding of laparotomy and/or imaging tests (abdominal ultrasonography, intestinal transit, abdominal CAT) was terminal ileitis (80%). "
01/01/1999 - "At laparotomy an ileitis was seen and then resected. "
04/01/1989 - "In addition, the risk of chronic ileitis increases with the number of previous laparotomies irrespective of delay or purpose: 10.1% after one laparotomy, 22.2% after two and 50% after three or more laparotomies. "
01/01/1989 - "At laparotomy Crohn's ileitis as well as an angiodysplastic lesion were found. "
11/01/2011 - "We investigated the impact of backwash ileitis on pouch outcome after restorative proctocolectomy with ileoanal pouch anastomosis. "
11/01/2005 - "This study aims to determine the incidence, demography, pathologic nature, and clinical significance of ileitis in ulcerative colitis patients who underwent restorative proctocolectomy. "
02/01/2015 - "Ulcerative ileitis (UI) after restorative proctocolectomy (RPC) and ileoanal pullthrough procedure (IAPP) is a rare condition described as inflammation of the terminal ileum proximal to the anastomosis. "
07/01/2013 - "Backwash ileitis and the risk of colon neoplasia in ulcerative colitis patients undergoing restorative proctocolectomy."
11/01/2011 - "Backwash ileitis does not affect pouch outcome in patients with ulcerative colitis with restorative proctocolectomy."
|5.||Colonic Pouches (S Pouch)
07/01/1992 - "Persistent ileitis after ileal salvage from a failed Kock pouch."
10/01/1991 - "This study aimed to characterise the mucosal cellular infiltrate in ileal reservoirs with and without pouchitis (reservoir ileitis). "
12/01/2011 - "Specifically, CD10 staining was lost in up to 10% of the mucosa in 1/12 ileostomies and 4/13 enteric anastomoses, in 10-80% of the mucosa in 9/10 cases of Crohn's ileitis, in 10-60% of the mucosa in 7/16 ileal pouches, and in 20-90% of the mucosa in 6/8 cases of backwash ileitis, usually in the presence of active inflammation. "
07/01/1994 - "Concentrations of interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-alpha) were determined by solid-phase ELISA in tissue homogenates of mucosal biopsy specimens obtained from pelvic ileal pouches in 13 patients with pouchitis (reservoir ileitis) and 17 with pouches without pouchitis. "